← All trials
NCT02117869
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2014
- Primary completion
- May 31, 2015
- Completion date
- May 31, 2015
- First posted
- Apr 21, 2014
- Last posted
- Jun 10, 2015
- Enrollment
- 12
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of FloridaLead sponsor
- University of FloridaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.